Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

INTERCEPTOR PLUS CORONARY FILTER SYSTEMS

K-Number: K073523 · 2008-08-01

ApplicantMedtronic, Inc.
Decision Date2008-08-01
Product CodeNFA
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

INTERCEPTOR PLUS CORONARY FILTER SYSTEMS is the device name listed in this FDA 510(k) record. The listed applicant is Medtronic, Inc.. It received FDA 510(k) clearance on 2008-08-01 under 510(k) number K073523. The device is classified under product code NFA. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the INTERCEPTOR PLUS CORONARY FILTER SYSTEMS?

INTERCEPTOR PLUS CORONARY FILTER SYSTEMS is a medical device that received FDA 510(k) clearance on 2008-08-01. The listed applicant is Medtronic, Inc.. The 510(k) number is K073523.

When did INTERCEPTOR PLUS CORONARY FILTER SYSTEMS receive FDA 510(k) clearance?

INTERCEPTOR PLUS CORONARY FILTER SYSTEMS received FDA 510(k) clearance on 2008-08-01, under 510(k) number K073523.

Who is the listed applicant for INTERCEPTOR PLUS CORONARY FILTER SYSTEMS?

The FDA 510(k) record lists Medtronic, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for INTERCEPTOR PLUS CORONARY FILTER SYSTEMS?

The FDA product code for INTERCEPTOR PLUS CORONARY FILTER SYSTEMS is NFA.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Medtronic, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K262913Protégé™ EverFlex™ Self-expanding Peripheral Stent SystemK262735LINQ II Insertable Cardiac Monitor (ICM) (LNQ22)K262005Affera Integrated Mapping SystemK261335VitalFlow Set with Balance™ BiosurfaceK261866Concerto Versa™ Detachable CoilK260195Elongated One-Piece Arterial (EOPA) 3D™ Arterial Cannulae

View all 182 devices →

Related Devices (Code: NFA)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K073563MODIFICATION TO PROXIS SYSTEMSt Jude MedicalK063785SPIDERFX EMBOLIC PROTECTION DEVICEEv3, Inc.K062870TRIACTIV FX EMBOLIC PROTECTION SYSTEM, MODEL PN 60040-02; -03Kensey Nash Corp.K060651PROXIS SYSTEM, MODEL EPS101St Jude MedicalK052523PROXIS SYSTEMVelocimed, Inc.K061332FILTERWIRE EZ EMBOLIC PROTECTION SYSTEM (2.25 MM-3.5 MM)Boston Scientific Corp

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑